Uma Borate
Clinical trials sponsored by Uma Borate, explained in plain language.
-
Scientists test Dual-Attack strategy for Tough-to-Treat blood cancer
Disease control Recruiting nowThis early-stage study is testing the safety and finding the best dose of a new two-drug combination (SNDX-5613 and gilteritinib) for adults with a specific form of acute myeloid leukemia (AML) that has come back or not responded to treatment. The drugs work together to block two…
Phase: PHASE1 • Sponsor: Uma Borate • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
New drug combo tested for Tough-to-Treat blood cancers
Disease control Recruiting nowThis study is testing a new combination of two drugs, axatilimab and azacitidine, for people with advanced or hard-to-treat blood cancers. The first part of the study aims to find the safest and most effective dose. The second part will see how well the drug combination works to …
Phase: PHASE1, PHASE2 • Sponsor: Uma Borate • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC
-
Could a simple shot stop a Pre-Cancerous blood condition from turning into cancer?
Prevention Recruiting nowThis study is testing whether a drug called canakinumab can prevent a high-risk blood condition (CCUS) from turning into blood cancer. About 110 adults with this condition will receive either the drug or a placebo injection to see if blocking inflammation delays or stops cancer d…
Phase: PHASE2 • Sponsor: Uma Borate • Aim: Prevention
Last updated Mar 20, 2026 14:47 UTC